Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.59 USD | -11.12% | -33.61% | -47.68% |
08/04 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
29/03 | Genenta Science S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 44.2M 47.25M 3.94B |
---|---|---|---|---|---|
Net income 2024 * | -15M -16.04M -1.34B | Net income 2025 * | -18M -19.25M -1.61B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.32
x | P/E ratio 2025 * |
-3.07
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.75% |
1 day | -11.12% | ||
1 week | -33.61% | ||
Current month | -26.00% | ||
1 month | -31.77% | ||
3 months | -36.05% | ||
6 months | -52.15% | ||
Current year | -47.68% |
Managers | Title | Age | Since |
---|---|---|---|
Bernhard Gentner
FOU | Founder | - | 24/14/24 |
Luigi Naldini
FOU | Founder | - | 24/14/24 |
Founder | 50 | 24/14/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Sirgo
CHM | Chairman | 70 | 01/22/01 |
Anthony Marucci
BRD | Director/Board Member | 62 | 20/21/20 |
Roger Abravanel
BRD | Director/Board Member | 77 | 20/21/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.59 | -11.12% | 11,122 |
25/24/25 | 2.914 | +14.28% | 11,459 |
24/24/24 | 2.55 | -29.75% | 62,693 |
23/24/23 | 3.63 | -8.02% | 679 |
22/24/22 | 3.947 | +1.17% | 1,251 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.68% | 47.18M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GNTA Stock